MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1002/alz.14317

Медицинская библиотека · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2024

Amyloid PET detects the deposition of brain Aβ earlier than CSF fluid biomarkers.

Lowe Val J, Mester Carly T, Lundt Emily S, Lee Jeyeon, Ghatamaneni Sujala, Algeciras-Schimnich Alicia, Campbell Michelle R, Graff-Radford Jonathan, Nguyen Aivi, Min Hoon-Ki, Senjem Matthew L, Machulda Mary M, Schwarz Christopher G, Dickson Dennis W, Murray Melissa E, Kandimalla Karunya K, Kantarci Kejal, Boeve Bradley, Vemuri Prashanthi, Jones David T, Knopman David, Jack Clifford R, Petersen Ronald C, Mielke Michelle M

СтатьяПоддержка NIH: внешняя программаПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

INTRODUCTION

Understanding the relationship between amyloid beta (Aβ) positron emission tomography (PET) and Aβ cerebrospinal fluid (CSF) biomarkers will define their potential utility in Aβ treatment. Few population-based or neuropathologic comparisons have been reported.

METHODS

Participants 50+ years with Aβ PET and Aβ CSF biomarkers (phosphorylated tau [p-tau]181/Aβ42, n = 505, and Aβ42/40, n = 54) were included from the Mayo Clinic Study on Aging. From these participants, an autopsy subgroup was identified (n = 47). The relationships of Aβ PET and Aβ CSF biomarkers were assessed cross-sectionally in all participants and longitudinally in autopsy data.

RESULTS

Cross-sectionally, more participants were Aβ PET+ versus Aβ CSF- than Aβ PET- versus Aβ CSF+ with an incremental effect when using Aβ PET regions selected for early Aβ deposition. The sensitivity for the first detection of Thal phase ≥ 1 in longitudinal data was higher for Aβ PET (89%) than p-tau181/Aβ42 (64%).

DISCUSSION: Aβ PET can detect earlier cortical Aβ deposition than Aβ CSF biomarkers. Aβ PET+ versus Aβ CSF- findings are several-fold greater using regional Aβ PET analyses and in peri-threshold-standardized uptake value ratio participants.

HIGHLIGHTS: Amyloid beta (Aβ) positron emission tomography (PET) has greater sensitivity for Aβ deposition than Aβ cerebrospinal fluid (CSF) in early Aβ development. A population-based sample of participants (n = 505) with PET and CSF tests was used. Cortical regions showing early Aβ on Aβ PET were also used in these analyses. Neuropathology was used to validate detection of Aβ by Aβ PET and Aβ CSF biomarkers.

Для цитирования: Lowe Val J, Mester Carly T, Lundt Emily S, Lee Jeyeon, Ghatamaneni Sujala, Algeciras-Schimnich Alicia, Campbell Michelle R, Graff-Radford Jonathan, Nguyen Aivi, Min Hoon-Ki, Senjem Matthew L, Machulda Mary M, Schwarz Christopher G, Dickson Dennis W, Murray Melissa E, Kandimalla Karunya K, Kantarci Kejal, Boeve Bradley, Vemuri Prashanthi, Jones David T, Knopman David, Jack Clifford R, Petersen Ronald C, Mielke Michelle M. Amyloid PET detects the deposition of brain Aβ earlier than CSF fluid biomarkers.. Alzheimer's & dementia : the journal of the Alzheimer's Association. 2024. DOI: 10.1002/alz.14317.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.